Ehlers–Danlos syndrome, hypermobility type: A characterization of the patients' lived experience
dc.contributor.author | Murray, Brittney | en_US |
dc.contributor.author | Yashar, Beverly M. | en_US |
dc.contributor.author | Uhlmann, Wendy R. | en_US |
dc.contributor.author | Clauw, Daniel J. | en_US |
dc.contributor.author | Petty, Elizabeth M. | en_US |
dc.date.accessioned | 2013-12-04T18:57:00Z | |
dc.date.available | 2015-01-05T13:54:43Z | en_US |
dc.date.issued | 2013-12 | en_US |
dc.identifier.citation | Murray, Brittney; Yashar, Beverly M.; Uhlmann, Wendy R.; Clauw, Daniel J.; Petty, Elizabeth M. (2013). "Ehlers–Danlos syndrome, hypermobility type: A characterization of the patients' lived experience." American Journal of Medical Genetics Part A 161(12): 2981-2988. | en_US |
dc.identifier.issn | 1552-4825 | en_US |
dc.identifier.issn | 1552-4833 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/101781 | |
dc.description.abstract | Hypermobility type Ehlers–Danlos syndrome (EDS‐HT) is an inherited connective tissue disorder clinically diagnosed by the presence of significant joint hypermobility and associated skin manifestations. This article presents a large‐scale study that reports the lived experience of EDS‐HT patients, the broad range of symptoms that individuals with EDS‐HT experience, and the impact these symptoms have on daily functioning. A 237‐item online survey, including validated questions regarding pain and depression, was developed. Four hundred sixty‐six (466) adults (90% female, 52% college or higher degree) with a self‐reported diagnosis of EDS‐HT made in a clinic or hospital were included. The most frequently reported symptoms were joint pain (99%), hypermobility (99%), and limb pain (91%). They also reported a high frequency of other conditions including chronic fatigue (82%), anxiety (73%), depression (69%), and fibromyalgia (42%). Forty‐six percent of respondents reported constant pain often described as aching and tiring/exhausting. Despite multiple interventions and therapies, many individuals (53%) indicated that their diagnosis negatively affected their ability to work or attend school. Our results show that individuals with EDS‐HT can experience a wide array of symptoms and co‐morbid conditions. The degree of constant pain and disability experienced by the majority of EDS‐HT respondents is striking and illustrates the impact this disorder has on quality of life as well as the clinical challenges inherent in managing this complex connective tissue disorder. © 2013 Wiley Periodicals, Inc. | en_US |
dc.publisher | Left Paw Press | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Ehlers–Danlos Syndrome | en_US |
dc.subject.other | Chronic Pain | en_US |
dc.subject.other | Joint Laxity | en_US |
dc.subject.other | Type III | en_US |
dc.subject.other | Connective Tissue Disorders | en_US |
dc.subject.other | Lived Experience | en_US |
dc.subject.other | Disability | en_US |
dc.subject.other | Hypermobility | en_US |
dc.title | Ehlers–Danlos syndrome, hypermobility type: A characterization of the patients' lived experience | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Genetics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/101781/1/ajmga36293.pdf | |
dc.identifier.doi | 10.1002/ajmg.a.36293 | en_US |
dc.identifier.source | American Journal of Medical Genetics Part A | en_US |
dc.identifier.citedreference | Germain DP, Herrera‐Guzman Y. 2004. Vascular Ehlers‐Danlos syndrome. Ann Genet 47: 1 – 9. | en_US |
dc.identifier.citedreference | Rombaut L, Malfait F, DeWandele I, Cools A, Thijs Y, DePaepe A, Calders P. 2011. Medication, Surgery, and physiotherapy among patients with hypermobility type of Ehlers‐Danlos syndrome. Arch Phys Med and Rehabil 92: 1106 – 1112. | en_US |
dc.identifier.citedreference | Sacheti A, Szemore J, Bernstein B, Tafas T, Schechter N, Tsipouras P. 1997. Chronic pain is a manifestation of the Ehlers Danlos syndrome. J Pain Symptom Manage 14: 88 – 93. | en_US |
dc.identifier.citedreference | Tinkle BT. 2008. Issues and management of joint hypermobility: A guide for the Ehlers Danlos syndrome hypermobility type and hypermobility syndrome, 1st edition. Green Fork: Left Paw Press. p 148. | en_US |
dc.identifier.citedreference | Adib N, Davies K, Grahame R, Woo P, Murray KJ. 2005. Joint hypermobility syndrome in childhood. A not so benign multisystem disorder ? Rheumatology 44: 744 – 750. | en_US |
dc.identifier.citedreference | Ainsworth SR, Aulicino PL. 1993. A survey of patients with Ehlers‐Danlos syndrome. Clin Orthop Relat Res 286: 250 – 256. | en_US |
dc.identifier.citedreference | Baeza‐Velasco, Gely‐Nargeot MC, Bulbena Vilarrasa A, Bravo JF, 2011. Joint hypermobility syndrome: Problems that require psychological intervention. Rhematol Int 31: 1131 – 1136. | en_US |
dc.identifier.citedreference | Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. 1998. Ehlers Danlos syndrome: Revised nosology, Villefrache 1997, 1998. Ehlers‐Danlos National Foundation (USA) and Ehlers‐Danlos Support Group (UK). Am J Med Genet 77: 31 – 37. | en_US |
dc.identifier.citedreference | Berglund B, Nordstrom G, Lutzen K. 2000. Living a restricted life with Ehlers Danlos Syndrome. Int J Nurs Stud 37: 111 – 118. | en_US |
dc.identifier.citedreference | Berglund B, Anne‐Cathrine M, Randers I. 2010. Dignity not fully upheld when seeking health care: Experiences expressed by individuals suffering from Ehlers‐Danlos syndrome. Disabil Rehabil 32: 1 – 7. | en_US |
dc.identifier.citedreference | Castori M, Camerota F, Celletti C, Danese C, Santilli V, Saraceni VM, Grammatico P. 2010. Natural history and manifestations of the hypermobility type Ehlers‐Danlos syndrome: A pilot study on 21 patients. Am J Med Genet Part A 152A: 556 – 564. | en_US |
dc.identifier.citedreference | Castori M, Celletti C, Camerota F. 2013. Ehlers‐Danlos syndrome hypermobility type: A possible unifying concept for various functional somatic syndromes. Rheumatol Int. 33: 819 – 821. | en_US |
dc.identifier.citedreference | Castori M, Morlino S, Celletti C, Celli M, Morrone A, Colombi M, Camerota F, Grammatico P. 2012. Management of pain and fatigue in the joint hypermobility syndrome (a.k.a. Ehlers‐Danlos syndrome, hypermobility type): Principles and proposal for a multidisciplinary approach. Am J Med Genet Part A 158A: 2055 – 2070. | en_US |
dc.identifier.citedreference | Davis NA. 2005. Invisible disability. Ethics 116: 153 – 213. | en_US |
dc.identifier.citedreference | Dow CM, Roche PA, Ziebland S. 2012. Talk of frustration in the narratives of people with chronic pain. Chronic Illn 8: 176 – 191. | en_US |
dc.identifier.citedreference | Fernandes NF, Schwartz RA. 2008. A “hyperextensive” review of Ehlers‐Danlos syndrome. Cutis 82: 242 – 248. | en_US |
dc.identifier.citedreference | Grahame R. 2009. Joint hypermobility syndrome pain. Curr Pain Headache Rep 13: 427 – 433. | en_US |
dc.identifier.citedreference | Hakim A, Grahame R. 2003. Joint hypermobility. Best Pract Res Clin Rheumatol 17: 989 – 1004. | en_US |
dc.identifier.citedreference | Maeland S, Assmus J, Berglund B. 2011. Subjective health complaints in individuals with Ehlers Danlos syndrome: A questionnaire study. Int J Nurs Stud 48: 720 – 724. | en_US |
dc.identifier.citedreference | Melzack R. 1987. The short‐form McGill Pain Questionnaire. Pain 30: 191 – 197. | en_US |
dc.identifier.citedreference | Radloff LS. 1977. The CES‐D scale: A self‐report depression scale for research in the general population. Appl Psychol Meas 1: 385 – 401. | en_US |
dc.identifier.citedreference | Remvig R, Engelbert RH, Berglund B, Bulbena A, Byers PH, Grahame R, Juul‐Kristensen B, Lindgren KA, Uitto J, Wekre LL. 2011. Need for a consensus on the methods by which to measure joint mobility and the definition of norms for joint hypermobility that reflect age, gender, and ethnic‐dependent variation: Is revision of criteria for joint hypermobility syndrome and Ehler‐Danols syndrome hypermobility type indicated ? Rheumatology 50: 1171 – 1173. | en_US |
dc.identifier.citedreference | Rombaut L, Malfait F, Cools A, De Paepe AD, Calders P. 2010. Musculoskeletal complaints, physical activity and health‐related quality of life among patients with the Ehlers‐Danlos syndrome hypermobility type. Disabil Rehabil 32: 1339 – 1345. | en_US |
dc.identifier.citedreference | Tinkle BT, Bird HA, Grahame R, Lavallee M, Levy HP, Sillence D. 2009. The lack of clinical distinction between the hypermobility type of Ehlers‐Danlos syndrome and the joint hypermobiltiy syndrome (a.k.a. hypermobility syndrome). Am M Med Genet Part A 149A: 2368 – 2370. | en_US |
dc.identifier.citedreference | Voermans NC, Knoop H, van de Kamp N, Hamel BC, Bleijenberg G, van Engelen BG. 2009. Fatigue is a frequent and clinically relevant problem in Ehlers‐Danlos syndrome. Semin Arthritis Rheum 40: 267 – 274. | en_US |
dc.identifier.citedreference | Voermans NC, Knoop H, Bleijenberg G, van Engelen BG. 2010. Pain in Ehlers‐Danlos syndrome is common, severe, and associated with functional impairment. J Pain Symptom Manage 40: 370 – 378. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.